Stock Analysis on Net
Stock Analysis on Net

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

Analysis of Debt

Advanced level


Total Debt (Carrying Amount)

Regeneron Pharmaceuticals Inc., balance sheet: debt

US$ in thousands

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Finance lease liabilities, current portion —  —  —  129,557  1,789 
Convertible senior notes, current portion —  —  —  —  10,802 
Finance lease liabilities, excluding current portion 713,900  708,500  703,453  351,569  362,919 
Total debt (carrying amount) 713,900  708,500  703,453  481,126  375,510 

Based on: 10-K (filing date: 2020-02-07), 10-K (filing date: 2019-02-07), 10-K (filing date: 2018-02-08), 10-K (filing date: 2017-02-09), 10-K (filing date: 2016-02-11).

Debt item Description The company
Total debt (carrying amount) Sum of the carrying values as of the balance sheet date of all debt plus capital lease obligations. Regeneron Pharmaceuticals Inc.’s total debt increased from 2017 to 2018 and from 2018 to 2019.

Total Debt (Fair Value)

Microsoft Excel LibreOffice Calc
Dec 31, 2019
Selected Financial Data (US$ in thousands)
Finance lease liabilities 713,900 
Convertible senior notes — 
Total debt (fair value) 713,900 
Financial Ratio
Debt, fair value to carrying amount ratio 1.00

Based on: 10-K (filing date: 2020-02-07).


Weighted-average Interest Rate on Debt

Weighted-average interest rate on debt: 3.05%

Interest Rate Debt Amount1 Interest Rate × Debt Amount Weighted-average Interest Rate2
3.05% 713,900  21,774 
Total 713,900  21,774 
3.05%

Based on: 10-K (filing date: 2020-02-07).

1 US$ in thousands

2 Weighted-average interest rate = 100 × 21,774 ÷ 713,900 = 3.05%